Axovant Announces Dosing of First Patient in Second Cohort of SUNRISE-PD Phase 2 Trial of AXO-Lenti-PD – Yahoo Finance

Axovant Announces Dosing of First Patient in Second Cohort of SUNRISE-PD Phase 2 Trial of AXO-Lenti-PD – Yahoo Finance
Axovant Announces Dosing of First Patient in Second Cohort of SUNRISE-PD Phase 2 Trial of AXO-Lenti-PD  Yahoo FinanceAxovant Gene Therapies Ltd. (AXGT), a clinical-stage company developing innovative gene therapies, announced the dosing of the first patient of the second ... read more
Source: Google NewsPublished on 2019-04-30